Efficacy and safety of CD30-targeted chimeric antigen receptor T-cell…
CD30-targeted CAR-T cell therapy shows consistent benefit across lymphoma studies, offering pooled evidence to guide treatment decisions for patients with limited options.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Diagnostic performance of urinary tumor DNA in urothelial carcinoma
Non-invasive urine tests for tumor DNA could catch bladder cancers earlier, sparing some patients from uncomfortable tissue biopsies while improving detection accuracy.
Near-term implementable findingExome-wide association study of blood lipids in 1,158,017 individuals…
Analyzing genetic variants in over 1.1 million diverse people reveals new cardiovascular risk factors, helping doctors better predict and prevent heart disease across different populations.
Promising but preliminaryClinical utility of liquid biopsy in distinguishing true progression…
Blood tests may help brain tumor doctors distinguish real cancer growth from harmless scar tissue, solving a frustrating problem where current imaging often fails them.
Standard additionA prospective study of physical activity and cardiometabolic diseases…
Exercise may reduce cancer risk partly by improving heart health and metabolism, suggesting fitness benefits compound in multiple protective ways.